 | • レポートコード：GIR-105X03768 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、慢性腎臓病–ミネラル・骨疾患（CKD-MBD）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。慢性腎臓病–ミネラル・骨疾患（CKD-MBD）の種類別市場規模（高リン血症制御、血中カルシウムレベル維持、PTHレベル制御、アシドーシス修正、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・慢性腎臓病–ミネラル・骨疾患（CKD-MBD）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Akebia、Astellas、Takeda、Vifor、Abbvie、Fresenius、Abbott、Novadiol、Japan Tobacco Company、Daiichi-Sankyo、Shield、Spectrum、OPKO、Ardelyx、Sanofi Genzyme、Amgen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：高リン血症制御、血中カルシウムレベル維持、PTHレベル制御、アシドーシス修正、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他 ・慢性腎臓病–ミネラル・骨疾患（CKD-MBD）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・慢性腎臓病–ミネラル・骨疾患（CKD-MBD）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・慢性腎臓病–ミネラル・骨疾患（CKD-MBD）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・慢性腎臓病–ミネラル・骨疾患（CKD-MBD）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・慢性腎臓病–ミネラル・骨疾患（CKD-MBD）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Other
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Other
The key market players for global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market are listed below:
Akebia
Astellas
Takeda
Vifor
Abbvie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi-Sankyo
Shield
Spectrum
OPKO
Ardelyx
Sanofi Genzyme
Amgen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Control Hyperphosphatemia
1.2.3 Maintain Blood Calcium Levels
1.2.4 Control PTH Level
1.2.5 Correct Acidosis
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.3.6 Other
1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size & Forecast
1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value (2016-2026))
1.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume (2016-2026)
1.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2026) & (USD/Kg)
1.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity Analysis
1.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Total Production Capacity (2016-2026)
1.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
1.6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
1.6.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Trends Analysis
2 Manufacturers Profiles
2.1 Akebia
2.1.1 Akebia Details
2.1.2 Akebia Major Business
2.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Astellas
2.2.1 Astellas Details
2.2.2 Astellas Major Business
2.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Vifor
2.4.1 Vifor Details
2.4.2 Vifor Major Business
2.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business
2.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Fresenius
2.6.1 Fresenius Details
2.6.2 Fresenius Major Business
2.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novadiol
2.8.1 Novadiol Details
2.8.2 Novadiol Major Business
2.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Japan Tobacco Company
2.9.1 Japan Tobacco Company Details
2.9.2 Japan Tobacco Company Major Business
2.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Daiichi-Sankyo
2.10.1 Daiichi-Sankyo Details
2.10.2 Daiichi-Sankyo Major Business
2.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Shield
2.11.1 Shield Details
2.11.2 Shield Major Business
2.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Spectrum
2.12.1 Spectrum Details
2.12.2 Spectrum Major Business
2.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.12.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 OPKO
2.13.1 OPKO Details
2.13.2 OPKO Major Business
2.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.13.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Ardelyx
2.14.1 Ardelyx Details
2.14.2 Ardelyx Major Business
2.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.14.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Sanofi Genzyme
2.15.1 Sanofi Genzyme Details
2.15.2 Sanofi Genzyme Major Business
2.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.15.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Amgen
2.16.1 Amgen Details
2.16.2 Amgen Major Business
2.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
2.16.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturer
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer Market Share
3.4.2 Top 6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer Market Share
3.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2016-2026)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2016-2026)
4.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026)
4.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026)
4.4 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026)
4.5 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026)
4.6 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Type (2016-2026)
5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2016-2026)
5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Application (2016-2026)
6.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2016-2026)
6.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2026)
7.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2026)
7.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
7.3.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2016-2026)
7.3.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2026)
8.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2026)
8.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
8.3.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2016-2026)
8.3.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2026)
9.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2026)
9.3 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region
9.3.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2026)
10.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2026)
10.3 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
10.3.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2016-2026)
10.3.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2026)
11.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2026)
11.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country
11.3.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Distributors
12.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application, (USD Million), 2021-2026
Table 3. Akebia Basic Information, Manufacturing Base and Competitors
Table 4. Akebia Major Business
Table 5. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 6. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Astellas Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Major Business
Table 9. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 10. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 14. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Vifor Basic Information, Manufacturing Base and Competitors
Table 16. Vifor Major Business
Table 17. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 18. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Abbvie Basic Information, Manufacturing Base and Competitors
Table 20. Abbvie Major Business
Table 21. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 22. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Major Business
Table 25. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 26. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abbott Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Major Business
Table 29. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 30. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novadiol Basic Information, Manufacturing Base and Competitors
Table 32. Novadiol Major Business
Table 33. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 34. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Japan Tobacco Company Basic Information, Manufacturing Base and Competitors
Table 36. Japan Tobacco Company Major Business
Table 37. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 38. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table 40. Daiichi-Sankyo Major Business
Table 41. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 42. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Shield Basic Information, Manufacturing Base and Competitors
Table 44. Shield Major Business
Table 45. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 46. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Spectrum Basic Information, Manufacturing Base and Competitors
Table 48. Spectrum Major Business
Table 49. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 50. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. OPKO Basic Information, Manufacturing Base and Competitors
Table 52. OPKO Major Business
Table 53. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 54. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Ardelyx Basic Information, Manufacturing Base and Competitors
Table 56. Ardelyx Major Business
Table 57. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 58. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Sanofi Genzyme Basic Information, Manufacturing Base and Competitors
Table 60. Sanofi Genzyme Major Business
Table 61. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 62. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Amgen Basic Information, Manufacturing Base and Competitors
Table 64. Amgen Major Business
Table 65. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Services
Table 66. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturer (2019-2021e) & (MT)
Table 68. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Company, (MT): 2020 VS 2021
Table 71. Head Office and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Site of Key Manufacturer
Table 72. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2016-2021e) & (MT)
Table 73. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026) & (MT)
Table 74. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2021e) & (MT)
Table 77. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (MT)
Table 78. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2021e) & (USD/Kg)
Table 81. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2021-2026) & (USD/Kg)
Table 82. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2021e) & (MT)
Table 83. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (MT)
Table 84. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2016-2021e) & (USD/Kg)
Table 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2021-2026) & (USD/Kg)
Table 88. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2016-2021e) & (MT)
Table 89. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (MT)
Table 90. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2021e) & (MT)
Table 93. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (MT)
Table 94. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2021e) & (MT)
Table 95. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (MT)
Table 96. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2016-2021e) & (MT)
Table 97. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (MT)
Table 98. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2021e) & (MT)
Table 101. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (MT)
Table 102. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2021e) & (MT)
Table 103. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (MT)
Table 104. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2016-2021e) & (MT)
Table 105. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026) & (MT)
Table 106. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2021e) & (MT)
Table 109. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (MT)
Table 110. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2021e) & (MT)
Table 111. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (MT)
Table 112. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2016-2021e) & (MT)
Table 113. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (MT)
Table 114. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2021e) & (MT)
Table 117. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (MT)
Table 118. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2021e) & (MT)
Table 119. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (MT)
Table 120. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2016-2021e) & (MT)
Table 121. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (MT)
Table 122. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016-2021e) & (MT)
Table 125. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (MT)
Table 126. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2016-2021e) & (MT)
Table 127. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (MT)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Distributors
Table 131. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Typical Customers
List of Figures
Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Picture
Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2020
Figure 3. Control Hyperphosphatemia
Figure 4. Maintain Blood Calcium Levels
Figure 5. Control PTH Level
Figure 6. Correct Acidosis
Figure 7. Other
Figure 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Drug Stores
Figure 13. Other
Figure 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2016-2026) & (MT)
Figure 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity (2016-2026) & (MT)
Figure 37. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
Figure 39. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
Figure 40. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends
Figure 41. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturer in 2020
Figure 42. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturer in 2020
Figure 43. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2016-2026)
Figure 47. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2016-2026)
Figure 48. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026) & (USD Million)
Figure 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026) & (USD Million)
Figure 51. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2016-2026) & (USD Million)
Figure 53. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2016-2026)
Figure 54. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2016-2026)
Figure 55. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2026) & (USD/Kg)
Figure 56. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2026)
Figure 57. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2016-2026)
Figure 58. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2016-2026) & (USD/Kg)
Figure 59. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2016-2026)
Figure 60. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2016-2026)
Figure 61. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2016-2026)
Figure 62. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2026)
Figure 63. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2016-2026)
Figure 64. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2016-2026)
Figure 65. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2016-2026)
Figure 66. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2026)
Figure 71. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2016-2026)
Figure 72. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2016-2026)
Figure 73. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2016-2026)
Figure 74. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
慢性腎疾患（CKD）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function. Scope of the Report: This report focuses on the Chronic Kidney Disease (CKD) Drugs in global market, especially in North America, Europe a…- 慢性閉塞性肺疾患の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 慢性閉塞性肺動脈の病気トリートメントの世界市場2018-2025 In 2018, the global Chronic Obstructive Pulmonary Disease Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Chro…
- 慢性閉塞性肺疾患薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic obstructive pulmonary disease ( COPD ) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Scope of the Report: This report focuses on the Chronic Obstructive Pulmonary Disease Drugs in global market, especially in North America, Europe and Asia-Pacific, Sou…
- 世界のインゲン豆市場 2021：企業別、地域別、種類・用途別 The Kidney Beans market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…